Investor Protection and Securities Reform Act of 2010

RBB Bancorp Declares Quarterly Cash Dividend of $0.16 Per Share

Retrieved on: 
Thursday, October 19, 2023
Banking, Professional Services, Finance, Federal Deposit Insurance Corporation, Bank, COVID-19, Consumer protection, Insurance, FRB, Investor Protection and Securities Reform Act of 2010, Terrorism, Acquisition, Failure, Royal Business Bank, LIBOR, FDIC, Weather, Earthquake, RAM, DBO, Bank Secrecy Act, Public Company Accounting Oversight Board, Provisions of the Dodd–Frank Wall Street Reform and Consumer Protection Act, London Interbank Bid Rate, SBA, Climate change, Financial Accounting Standards Board, Risk, Pandemic, Annual report

RBB Bancorp (NASDAQ: RBB ) and its subsidiaries, Royal Business Bank ("the Bank") and RBB Asset Management Company ("RAM"), collectively referred to herein as "the Company", announced that its Board of Directors has declared a quarterly cash dividend of $0.16 per share.

Key Points: 
  • RBB Bancorp (NASDAQ: RBB ) and its subsidiaries, Royal Business Bank ("the Bank") and RBB Asset Management Company ("RAM"), collectively referred to herein as "the Company", announced that its Board of Directors has declared a quarterly cash dividend of $0.16 per share.
  • The dividend is payable on November 10, 2023 to common shareholders of record as of October 30, 2023.
  • RBB Bancorp is a bank holding company headquartered in Los Angeles, California.
  • As of June 30, 2023, the Company had total assets of $4.1 billion.

RBB Bancorp Announces Termination of Agreement to Acquire Gateway Bank, F.S.B.

Retrieved on: 
Thursday, September 28, 2023
Finance, Banking, Professional Services, Small Business, Asset Management, Insurance, Financial Accounting Standards Board, Failure, Investor Protection and Securities Reform Act of 2010, Pandemic, Acquisition, Public Company Accounting Oversight Board, SBA, Provisions of the Dodd–Frank Wall Street Reform and Consumer Protection Act, Risk, Consumer protection, Federal Deposit Insurance Corporation, LIBOR, COVID-19, FDIC, Terrorism, Bank Secrecy Act, Climate change, Earthquake, Annual report, FRB, F.S.B, DBO, London Interbank Bid Rate, Weather, Bank

RBB Bancorp (NASDAQ:RBB) announced today that, effective September 28, 2023, Gateway Bank, F.S.B.

Key Points: 
  • RBB Bancorp (NASDAQ:RBB) announced today that, effective September 28, 2023, Gateway Bank, F.S.B.
  • announced that it and RBB Bancorp have mutually agreed to terminate the definitive agreement originally entered into on December 28, 2021.
  • RBB Bancorp is a community-based financial holding company headquartered in Los Angeles, California.
  • These forward-looking statements are subject to risks and uncertainties that could cause actual results, performance and/or achievements to differ materially from those projected.

Owlet Announces First Quarter 2023 Financial Results

Retrieved on: 
Thursday, May 11, 2023
Family, Health, Consumer, Parenting, Children, Baby, Maternity, General Health, Operating cost, Marketing, Conference call, Parent, Telephone, GAAP, Risk, Privacy, De novo, Reform Acts, Certification, Net, EBITDA, Pandemic, Vii, Access code, Investor Protection and Securities Reform Act of 2010, Depreciation, FDA, Benchmarking, Regulation of tobacco by the U.S. Food and Drug Administration, Conference, NYSE, Food, OWLT, Video game, Cryptocurrency, Pharmaceutical industry, Bookkeeping, Risk management, Insurance, Owlet

Owlet, Inc. (“Owlet” or the “Company”) (NYSE:OWLT) today reported financial results for the first quarter ended March 31, 2023.

Key Points: 
  • Owlet, Inc. (“Owlet” or the “Company”) (NYSE:OWLT) today reported financial results for the first quarter ended March 31, 2023.
  • Cost of revenues for the first quarter of 2023 was approximately $6.6 million with a gross margin of 39.3%.
  • Adjusted EBITDA loss was approximately $5.8 million in first quarter 2023, compared to $18 million for the first quarter of 2022.
  • Net loss per share was ($0.11) for the first quarter of 2023, compared to ($0.26) for the first quarter of 2022.

RBB Bancorp Receives NASDAQ Notice on Late Filing of its Form 10-K

Retrieved on: 
Friday, April 7, 2023
Banking, Professional Services, Finance, Bank statement, Companies (1st Amendment) Act, 2015, Form 10-K, Risk, SOX, Reform Acts, Royal Business Bank, Notice, Annual report, Form, SBA, Investor Protection and Securities Reform Act of 2010, Security (finance), Bank

The Company filed the Form 10-K on April 7, 2023.

Key Points: 
  • The Company filed the Form 10-K on April 7, 2023.
  • This announcement is made in compliance with Nasdaq Listing Rule 5810(b), which requires prompt disclosure of receipt of a deficiency notification.
  • RBB Bancorp is a community-based financial holding company headquartered in Los Angeles, California.
  • You should carefully review the risk factors described in the Form 10-K for the year ended December 31, 2021 and Amendment No.

Sarepta Therapeutics Announces That U.S. FDA has Accepted for Filing and Granted Priority Review for the Biologics License Application for SRP-9001, Sarepta’s Gene Therapy for the Treatment of Ambulant Individuals with Duchenne Muscular Dystrophy

Retrieved on: 
Monday, November 28, 2022
COVID-19, Gene editing, Sarepta Therapeutics, Sarepta, Degenerative disease, Dystrophin, Food, RNA, Mutation, United States Patent and Trademark Office, Four-year junior college, SRPT, Safety, Partnership, Therapy, Shock, Patient, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Duchenne muscular dystrophy, Heart failure, Investor Protection and Securities Reform Act of 2010, Annual report, Priority review, File, Disease, Security (finance), Muscular dystrophy, DMD, Muscle weakness, Heart, Risk, Walking, Patent, Roche, EC, FDA, BLA, Medical device, Pharmaceutical industry, Duchenne

CAMBRIDGE, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has accepted the Company's Biologics License Application (BLA) seeking accelerated approval of SRP-9001 (delandistrogene moxeparvovec) for the treatment of ambulant individuals with Duchenne muscular dystrophy. SRP-9001 has been granted Priority Review by the FDA, with a regulatory action date of May 29, 2023.

Key Points: 
  • SRP-9001 has been granted Priority Review by the FDA, with a regulatory action date of May 29, 2023.
  • We are delighted to announce that the FDA has accepted Sareptas BLA for SRP-9001 for filing and priority review, said Doug Ingram, president and chief executive officer, Sarepta Therapeutics.
  • SRP-9001 is an investigational gene therapy for Duchenne being developed in partnership with Roche.
  • For a detailed description of risks and uncertainties Sarepta faces, you are encouraged to review the SEC filings made by Sarepta.

Republic First Bancorp, Inc. Receives Notice of Additional Filing Delinquency From Nasdaq

Retrieved on: 
Friday, November 18, 2022
Federal Deposit Insurance Corporation, Reform Act, Panel, Republic First Bancorp, Form 10-K, Bank, ATM, Annual report, Security (finance), Risk, Investor Protection and Securities Reform Act of 2010, Form, Republic Bank, Commission

On October 26, 2022, the Company filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2021 with the Commission.

Key Points: 
  • On October 26, 2022, the Company filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2021 with the Commission.
  • Additionally, on November 18, 2022, the Company filed its Quarterly Report on Form 10-Q for the three months ended March 31, 2022 with the Commission.
  • Republic First Bancorp, Inc. is the holding company for Republic First Bank, which does business under the name Republic Bank.
  • Republic Bank is a full-service, state-chartered commercial bank, whose deposits are insured up to the applicable limits by the Federal Deposit Insurance Corporation.

HomeStreet Reports Third Quarter 2022 Results

Retrieved on: 
Monday, October 24, 2022
Professional Services, Small Business, Other Construction & Property, Finance, Construction & Property, Banking, Pressure, U.S. Securities and Exchange Commission, CFO, Time, Sale, Mission statement, Growth, Investor Protection and Securities Reform Act of 2010, Employment, The Company, Bank, Privacy, Income, National Association of Affordable Housing Lenders, Security (finance), GAAP, Nasdaq, Forecasting, Private Securities Litigation Reform Act, HomeStreet Bank, Reform Act, Company, Equal housing lender, Industry, Access code, Information technology, Board, CEO, Face, Tax, Environment, Forward-looking statement, FDIC, Failure, COVID-19, Risk management

HomeStreet, Inc. (Nasdaq: HMST) (including its consolidated subsidiaries, the "Company," "HomeStreet" or "we"), the parent company of HomeStreet Bank, today announced the financial results for the quarter ended September 30, 2022.

Key Points: 
  • HomeStreet, Inc. (Nasdaq: HMST) (including its consolidated subsidiaries, the "Company," "HomeStreet" or "we"), the parent company of HomeStreet Bank, today announced the financial results for the quarter ended September 30, 2022.
  • However, the growth in earning assets more than offset the impact of a lower net interest margin and our net interest income grew 5% quarter over quarter.
  • HomeStreet, Inc. (Nasdaq: HMST), the parent company of HomeStreet Bank, will conduct a quarterly earnings conference call on Tuesday, October 25, 2022 at 1:00 p.m.
  • Mark K. Mason, CEO and President, and John M. Michel, CFO, will discuss third quarter 2022 results and provide an update on recent events.

KBRA Assigns AA+ Rating, Stable Outlook to TBTA’s PMT Senior Lien Green Bonds, Series 2022E (Climate Bond Certified)

Retrieved on: 
Thursday, October 20, 2022
Professional Services, Finance, National Association of Insurance Commissioners, Climate bond, Triborough Bridge, Union, U.S. Securities and Exchange Commission, Metropolitan Transportation Authority, Outlook, Insurance commissioner, CRA, European Securities and Markets Authority, ESG, LLC, National Association, Series (botany), Ontario Securities Commission, MTA, Investor Protection and Securities Reform Act of 2010, PMT, Ban, KBRA, Tunnel, Société des Produits Nestlé S.A. v. Cadbury UK Limited, Prospectus, TBTA, Credit, Issuer, Security (finance), Public utility, Telescopic sight

KBRA assigns a long-term AA+ rating to the Triborough Bridge and Tunnel Authority (TBTA) Payroll Mobility Tax (PMT) Senior Lien Green Bonds, Series 2022E (Climate Bond Certified), which consists of:

Key Points: 
  • KBRA assigns a long-term AA+ rating to the Triborough Bridge and Tunnel Authority (TBTA) Payroll Mobility Tax (PMT) Senior Lien Green Bonds, Series 2022E (Climate Bond Certified), which consists of:
    Payroll Mobility Tax Senior Lien Green Bonds, Subseries 2022E-1 (Climate Bond Certified)
    Payroll Mobility Tax Senior Lien Variable Rate Refunding Green Bonds, Subseries 2022E-2a (Secured Overnight Financing Rate Tender Notes Climate Bond Certified)
    Payroll Mobility Tax Senior Lien Refunding Green Bonds, Subseries 2022E-2b (Climate Bond Certified)
    The Outlook for all of the above bonds is Stable.
  • At the same time, KBRA affirms the long-term AA+ rating, with a Stable Outlook, on the outstanding PMT Senior Lien Bonds issued by the TBTA and the short-term K1+ rating on the outstanding PMT Bond Anticipation Notes (BANs) issued by the TBTA and Metropolitan Transportation Authority (MTA).
  • Kroll Bond Rating Agency, LLC (KBRA) is a full-service credit rating agency registered with the U.S. Securities and Exchange Commission as an NRSRO.
  • Kroll Bond Rating Agency Europe Limited is registered as a CRA with the European Securities and Markets Authority.

Patrick Industries, Inc. Announces Third Quarter 2022 Earnings Release and Conference Call Webcast on October 27, 2022

Retrieved on: 
Thursday, October 13, 2022
St Patrick's Industrial School, Upton, U.S. Securities and Exchange Commission, Interest, SEC, Annual report, NASDAQ, Security (finance), Multimedia, Private Securities Litigation Reform Act, Investor Protection and Securities Reform Act of 2010, Company, Solution, Risk, Public relations, RV

ELKHART, Ind., Oct. 13, 2022 /PRNewswire/ -- Patrick Industries, Inc. (NASDAQ: PATK) today announced that it expects to release its third quarter and nine months 2022 financial results before the market opens on Thursday, October 27, 2022.

Key Points: 
  • ELKHART, Ind., Oct. 13, 2022 /PRNewswire/ -- Patrick Industries, Inc. (NASDAQ: PATK) today announced that it expects to release its third quarter and nine months 2022 financial results before the market opens on Thursday, October 27, 2022.
  • Patrick Industries also expects to host a conference call on Thursday, October 27, 2022 at 10:00 a.m. Eastern Time to discuss results and other business matters.
  • Participants on the call will be Andy Nemeth Chief Executive Officer, Jeff Rodino President, and Jake Petkovich Chief Financial Officer.
  • Interested parties are invited to listen to a live webcast of the call on Patrick's website at www.patrickind.com under "For Investors."

Sarepta Therapeutics Presents New Data from its Gene Therapy and RNA Platforms at World Muscle Society 2022

Retrieved on: 
Friday, October 7, 2022
LinkedIn, U.S. Securities and Exchange Commission, SEC, Review, Annual report, Patient, Gene editing, RNA, Twitter, Research, Instagram, Security (finance), Comparison, Degenerative disease, Sarepta, DMD, Duchenne muscular dystrophy, Company, United States Patent and Trademark Office, Investor Protection and Securities Reform Act of 2010, Patent, Muscular dystrophy, Risk, Public relations, Duchenne, Facebook, Survival

Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing.

Key Points: 
  • Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing.
  • We routinely post information that may be important to investors in the 'For Investors' section of our website at www.sarepta.com .
  • For a detailed description of risks and uncertainties Sarepta faces, you are encouraged to review the SEC filings made by Sarepta.
  • Sarepta does not undertake any obligation to publicly update its forward-looking statements based on events or circumstances after the date hereof, except as required by law.